Page 7 - 2021_06-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
1714 Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma Naoki Oishi et al.
https://doi.org/10.3324/haematol.2019.245860
Plasma Cell Disorders
1725 Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)
Jesus San-Miguel et al.
https://doi.org/10.3324/haematol.2019.243790
Letters to the Editor
1733 The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database
Hannah M. Cherniawsky et al.
https://doi.org/10.3324/haematol.2020.259093
1737 No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma Shin Yeu Ong et al.
https://doi.org/10.3324/haematol.2020.269209
1740 Pituitary iron and factors predictive of fertility status in transfusion-dependent thalassemia Sylvia T. Singer et al.
https://doi.org/10.3324/haematol.2020.252726
1745 Antimicrobial resistance is a risk factor for mortality in adults with sickle cell disease Andrew Srisuwananukorn et al.
https://doi.org/10.3324/haematol.2020.267872
1749 Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysis Kenneth I. Ataga et al.
https://doi.org/10.3324/haematol.2020.267419
1754 Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact Pablo Mozas et al.
https://doi.org/10.3324/haematol.2020.263228
1758 Homozygous Southeast Asian ovalocytosis in five live-born neonates Amanda A. Lavinya et al.
https://doi.org/10.3324/haematol.2020.268581
1762 Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance Stine U. Mikkelsen et al.
https://doi.org/10.3324/haematol.2020.263319
1767 Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use
Auriane Lesieur et al.
https://doi.org/10.3324/haematol.2020.260133
1770 Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC) John N. Brewin et al.
https://doi.org/10.3324/haematol.2020.265827
1774 MK2 is a therapeutic target for high-risk multiple myeloma Chunyan Gu et al.
https://doi.org/10.3324/haematol.2017.182121
Comment
1778 Breast dose matters Renee M. Moadel et al.
https://doi.org/10.3324/haematol.2019.219584
Haematologica 2021; vol. 106 no. 6 - June 2021 http://www.haematologica.org/